SNDX
#2060
Syndax Pharmaceuticals, Inc. - Common Stock
20.1 0 USD
+0.04%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
+4.20%
Changement Mensuel
+5.73%
Evolution sur 6 mois
-6.99%
Changement Annuel
+21.82%
Clôture Précédente
19.2 9
Open
20.1 0
Low
20.1 0
High
20.1 0
Volume
188
Financials
- Market Capitalization 1.79 B
- Employee 298
- Founded 2005
- CEO N/A
- Website www.syndax.com
- Headquarter Delaware, United States
- FIGI BBG000R33JY1
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-8.71
ratio cours/chiffre d'affaires
7.61
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2040 |  TSHA Taysha Gene Therapies, Inc. - Common Stock | 5.70 USD | +0.18% | -7.32% | -3.23% | +96.55% | 1.86 B USD | ||
| 2047 |  INBX Inhibrx Biosciences, Inc. - Common Stock | 124.66 USD | -1.61% | +1.35% | +52.28% | +54.70% | 1.83 B USD | ||
| 2067 |  RXRX Recursion Pharmaceuticals, Inc. - Class A Common Stock | 3.33 USD | -2.06% | -4.86% | +9.90% | -27.45% | 1.78 B USD | ||
| 2070 |  NTLA Intellia Therapeutics, Inc. - Common Stock | 12.69 USD | -0.31% | -5.16% | +19.83% | -7.51% | 1.78 B USD |